🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
RBC Bioscience Corporation (TPEX:6848)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.60
-1.45 (-7.23%)
Nov 20, 2026, 1:48 PM CST

RBC Bioscience Revenue

RBC Bioscience had revenue of 108.59M TWD in the half year ending June 30, 2026, a decrease of -2.25%. This brings the company's total for the last twelve months to 209.59M, down -0.57% year-over-year. In the year 2025, RBC Bioscience had annual revenue of 219.71M with 7.05% growth. That makes RBC Bioscience the 39,207th largest company in the world by revenue and 2,034th in Taiwan.

Revenue (ttm)
209.59M
Revenue Growth
-0.57%
P/S Ratio
1.27
Revenue / Employee
4.19M
Employees
50
Market Cap
265.49M

Revenue Chart

Revenue by Geography

  • Europe 146.34M 66.6%
  • Asia 31.69M 14.4%
  • Africa 14.51M 6.6%
  • Taiwan 14.31M 6.5%
  • America 12.84M 5.8%
  • Other Countries 21.00K 0.0%
Fiscal year ended Dec 31, 2025 See the full RBC Bioscience breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025219.71M14.46M7.05%
Dec 31, 2024205.25M32.78M19.01%
Dec 31, 2023172.47M-1.42M-0.82%
Dec 31, 2022173.89M-77.29M-30.77%
Dec 31, 2021251.18M-323.98M-56.33%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.